Search Back New search Go to resultsDiseaseMain groupPediatric Oncology and HematologyProtocol groupHematologic Diseases (ped.)DiseaseHemophagocytic LymphohistiocytosisSubgroupICD10D76.1MeSHLymphohistiocytosis, HemophagocyticSequencePAED ETOP150/DEXA10, HLH, C1 (PID665) -|- C2 (PID666) -|- C3+ (PID667)ChemotherapyChemo-substanceDexamethasoneEtoposideMethotrexateChemo-substanceDexamethasoneEtoposideMethotrexateChemo-substanceDexamethasoneEtoposideMethotrexateChemo-substanceDexamethasoneEtoposideMethotrexateNo. Substances12 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionCiclosporin ACotrimoxazoleFluconazoleFolinic acidGranisetronSupportive substanceBalanced Crystalloid SolutionCiclosporin ACotrimoxazoleFluconazoleFolinic acidGranisetronSupportive substanceBalanced Crystalloid SolutionCiclosporin ACotrimoxazoleFluconazoleFolinic acidGranisetronSupportive substanceBalanced Crystalloid SolutionCiclosporin ACotrimoxazoleFluconazoleFolinic acidGranisetronNo. Substances1345Protocol classificationTherapy classificationcurrent standardIntensityStandard doseTherapy indicationFirst lineTherapy phaseInductionMaintenanceTherapy intentioncurativeRisksEmetogenicityEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorEhl SDiseaseHämophagozytische LymphohistiozytoseHämophagozytische Lymphohistiozytose des KindesOriginCenter for Chronic Immunodeficiency, Faculty of Medicine, University of Freiburg, Freiburg, GermanyCenter for Chronic Immunodeficiency, Faculty of Medicine, University of Freiburg, Freiburg, Germany, HLH-94Protocols in Revision 4 protocols foundProtocols under revision.PAED Etoposide 150 / Dexamethasone (5 / 2.5 / 1.25), Hemophagocytic Lymphohistiocytosis, cycle 2 (PID666 V1.0)PAED Etoposide 150 / Dexamethasone 10, Hemophagocytic Lymphohistiocytosis, Cycle 1 (PID665 V1.0)PAED Etoposide 150 / Dexamethasone 10, Hemophagocytic Lymphohistiocytosis, Cycle 3+ (PID667 V1.0)PAED Methotrexate 12, Hemophagocytic Lymphohistiocytosis (PID672 V1.2)
